World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 6 February 2017
Main ID:  ISRCTN71463496
Date of registration: 14/08/2015
Prospective Registration: No
Primary sponsor: Birmingham Children's Hospital R&D Department
Public title: Continuous monitoring of body electric signals in Paediatric Intensive Care
Scientific title: Feasibility of continuous surface electro-gastrography (sEGG) and surface electro-myography (sEMG) monitoring in Paediatric Intensive Care
Date of first enrolment: 23/06/2015
Target sample size: 5
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN71463496
Study type:  Observational
Study design:  Observational single-center feasibility medical device study within CE marked intended use (Not Specified)  
Phase: 
Countries of recruitment
United Kingdom
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Balazs    Fule
Address:  Birmingham Children's Hospital PICU Research Office Steelhouse Lane B4 6NH Birmingham United Kingdom
Telephone: +44 121 333 9850
Email: balazs.fule@bch.nhs.uk
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Paediatric ICU patients with spontaneous breathing activity
2. Age between term and 16 years

Exclusion criteria: 1. Preterm infants
2. Muscle relaxant infusion at enrollment
3. Open abdomen after abdominal surgery
4. Open skin after sternotomy
5. Burns affecting the torso
6. Skin conditions (limiting use of ECG sensors)


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Testing continuous surface electro-gastrography (sEGG) and surface electro-myography (sEMG)
Not Applicable
Intervention(s)
Acquisuition of surface biopotentials (such as ECG, electromyography and electrogastrography signals) from a set of (8) surface electrodes over a period of 48 hours.
Primary Outcome(s)
Feasibility of continuously monitoring ECG, EGG and EMG signals at the same time. Measurements taken at baseline and then at every hour of data collection.
Secondary Outcome(s)
To identify potential noises that may distort data quality. The presence of electric signals will be decided by expert opinion to provide data quality and quantity measures.
Secondary ID(s)
IRAS project ID 157604
Source(s) of Monetary Support
Birmingham Children's Hospital, Inbiolab BV
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history